Curevac N.V. (CVAC)
3.53 +0.06 (+1.73%) 04/29/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 3.53 unch (unch) 17:24 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | CVAC | OCS | ABCL | ||
| Company | Curevac N.V. | Oculis Holding Ag | Abcellera Biologics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.47 | 17.57 | 2.59 | ||
| High | 3.76 | 17.65 | 2.63 | ||
| Low | 3.47 | 17.35 | 2.54 | ||
| Last | 3.53 | 17.57 | 2.55 | ||
| Change | +0.06 | -0.29 | -0.04 | ||
| % Change | +1.73% | -1.62% | -1.54% | ||
| Volume | 928,500 | 27,200 | 3,401,100 | ||
| 20-Day Average Volume | 606,160 | 44,075 | 4,314,835 | ||
| Previous Close | 3.47 | 17.86 | 2.59 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.06 | 17.20 | 2.33 | ||
| 20-Day Raw Stochastic | 82.49% | 70.00% | 83.54% | ||
| 20-Day Relative Strength | 60.38% | 46.65% | 52.76% | ||
| Weighted Alpha | +7.29 | +32.06 | -32.42 | ||
| Today's Opinion | 8% Buy | 8% Sell | 40% Sell | ||
| Previous Opinion | 8% Buy | 8% Buy | 40% Sell | ||
| Last Month's Opinion | 40% Sell | 56% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.66% since 04/22/25 | -1.18% since 04/22/25 | +1.19% since 04/22/25 | ||
| Low | 3.13 on 04/23/25 | 16.77 on 04/25/25 | 2.47 on 04/28/25 | ||
| High | 3.76 on 04/29/25 | 18.38 on 04/24/25 | 2.68 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +18.46% since 03/28/25 | -8.39% since 03/28/25 | +10.39% since 03/28/25 | ||
| Low | 2.47 on 04/07/25 | 14.00 on 04/09/25 | 1.89 on 04/07/25 | ||
| High | 3.76 on 04/29/25 | 19.98 on 03/31/25 | 2.68 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -8.79% since 01/29/25 | -20.68% since 01/29/25 | -20.31% since 01/29/25 | ||
| Low | 2.47 on 04/07/25 | 14.00 on 04/09/25 | 1.89 on 04/07/25 | ||
| High | 3.95 on 02/06/25 | 23.01 on 01/31/25 | 3.60 on 02/18/25 | ||
| 6-Month | |||||
| %Chg | +22.15% since 10/29/24 | +3.54% since 10/29/24 | -9.89% since 10/29/24 | ||
| Low | 2.37 on 11/20/24 | 14.00 on 04/09/25 | 1.89 on 04/07/25 | ||
| High | 5.00 on 01/07/25 | 23.08 on 01/13/25 | 3.68 on 01/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 778,453 | 779,803 | 771,789 | ||
| Shares Outstanding, K | 224,338 | 43,662 | 297,988 | ||
| Annual Sales | 579,120,000 | 780,000 | 28,830,000 | ||
| Annual Net Income | 175,500,000 | -97,430,000 | -162,860,000 | ||
| Last Quarter Sales | 7,040,000 | 250,000 | 5,050,000 | ||
| Last Quarter Net Income | -41,490,000 | -23,330,000 | -34,210,000 | ||
| 60-Month Beta | 2.48 | 0.19 | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 04/10/25 | -0.76 on 03/11/25 | -0.11 on 02/27/25 | ||
| Latest Earnings Date | 05/22/25 | 05/14/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 3.94 | 0.00 | 0.00 | ||